We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509

News   Dec 10, 2009

 
Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509
 
 
 

RELATED ARTICLES

Mathematical Method Provides Deeper Understanding of Drug Interactions

News

Researchers at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences have developed a new methodology characterizing more precisely how drugs influence each other when combined during treatment.

READ MORE

Blood Test Could Reveal High Risk Heart Patients in Need of Treatment

News

Without occasionally looking under the hood, it’s difficult to predict whether expensive car repairs lie ahead. In a similar way, preventive cardiologists are looking for ways to detect early stage heart disease in people who aren’t currently in treatment.

READ MORE

Compound Targets Previously “Undruggable” STAT3 To Combat Cancer

News

A compound has been developed that targets transcription factor STAT3, offering a new approach to a previously “undruggable” target.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE